AngioDynamics issues product recall pending FDA review  
  SEARCH: Sign In | Register | Contact Us | Site Map | Home  

Resources for Food and Drug Administration (FDA)

AngioDynamics issues product recall pending FDA review

www.bizjournals.com

AngioDynamics, Inc. is voluntarily recalling all hospital inventory of Centros, a catheter used in dialysis.

The Queensbury, N.Y.-based medical device manufacturer said it became aware that the catheter cuff, a component intended to anchor the catheter in the tissue just below the skin, was inadequately attached to the catheter in a few instances.

AngioDynamics (Nasdaq: ANGO) has identified the cause of the cuff problem and believes it is related to an outside manufacturer's production process. Pending a review by the U.S. Food and Drug Administration, shipments of Centros are expected to resume during the company's fiscal third quarter, which begins Dec. 1.

View the Resource



Share or bookmarklet this web page at:





Google
Privacy Policy | Terms & Conditions | Support | Directory Links | Contact Us | Site Map | Home
Copyright © 2007-2008 ComplianceHome.com. A SUPREMUS GROUP venture. All rights reserved.